Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy

Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy

Purpose To evaluate predictive factors associated with detectable prostate-specific antigen (PSA) and describe clinical recurrence (CR) and cancer-specific mortality (CSM) after robot-assisted radical prostatectomy (RARP). Methods The study included 2500 patients who were treated with RARP at a sing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical & translational oncology 2018-08, Vol.20 (8), p.1004-1010
Hauptverfasser: García-Barreras, S., Rozet, F., Nunes-Silva, I., Srougi, V., Sanchez-Salas, R., Barret, E., Galiano, M., Cathelineau, X.
Format: Artikel
Sprache:eng
Schlagworte:
Medicine
Medicine & Public Health
Oncology
Research Article
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To evaluate predictive factors associated with detectable prostate-specific antigen (PSA) and describe clinical recurrence (CR) and cancer-specific mortality (CSM) after robot-assisted radical prostatectomy (RARP). Methods The study included 2500 patients who were treated with RARP at a single institution between 2000 and 2016. All patients had clinically localized PCa. Patients were divided into two groups according to PSA value at 6 weeks after surgery: undetectable ( n  = 2271; PSA 
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-017-1812-1